A

Amicogen Inc
KOSDAQ:092040

Watchlist Manager
Amicogen Inc
KOSDAQ:092040
Watchlist
Price: 1 786 KRW -2.78%
Market Cap: 99.5B KRW

Wall Street
Price Targets

Price Targets Summary
Amicogen Inc

There are no price targets for Amicogen Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Amicogen Inc Competitors:
Price Targets
AGIO
Agios Pharmaceuticals Inc
12% Upside
ARX
Aroa Biosurgery Ltd
22% Upside
EDIT
Editas Medicine Inc
128% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
31% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
48% Upside
PGEN
Precigen Inc
107% Upside
GNS
Genus PLC
15% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
29% Upside

Revenue
Forecast

Revenue Estimate
Amicogen Inc

For the last 12 years the compound annual growth rate for Amicogen Inc's revenue is 22%. The projected CAGR for the next 3 years is -11%.

22%
Past Growth
-11%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Amicogen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Amicogen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-73%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Amicogen Inc's stock price target?
Not Available

Amicogen Inc doesn't have any price targets made by Wall Street professionals.

What is Amicogen Inc's Revenue forecast?
Projected CAGR
-11%

For the last 12 years the compound annual growth rate for Amicogen Inc's revenue is 22%. The projected CAGR for the next 3 years is -11%.

Back to Top